Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sean Calloway

Sports Medicine Greenwood, IN Medical Doctor

NPI 1780979856 CMS profile 1398038

1401 W County Line Rd, Greenwood, IN 46142

Open in the dashboard

General payments

$130,007

299 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sean Calloway of Greenwood, IN is reported in the CMS Open Payments database as having received $130,007 across 299 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $31,662 40
2024 General $22,190 48
2023 General $24,767 57
2022 General $27,459 57
2021 General $11,640 38
2020 General $5,364 19
2019 General $6,925 40

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sean Calloway
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Sean Calloway were reported at $31,662. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Sean Calloway Sports Medicine median Middle half National median
2019 $6,925 $1,176 $199–$4,249 $163
2020 $5,364 $708 $96–$2,890 $114
2021 $11,640 $1,213 $152–$3,994 $132
2022 $27,459 $1,230 $159–$3,998 $149
2023 $24,767 $584 $146–$2,836 $160
2024 $22,190 $628 $163–$3,168 $164
2025 $31,662 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $111,659 230 payments
  2. Crossroads Orthopedics, LLC $14,550 33 payments
  3. MF Med $1,242 8 payments
  4. RTI Surgical, Inc $1,042 3 payments
  5. Stryker Corporation $852 13 payments
  6. DePuy Synthes Sales Inc. $281 4 payments
  7. Gentleman Orthopedic Solutions $223 2 payments
  8. Smith+Nephew, Inc. $80 3 payments
  9. Elite Orthopedics, LLC $39 1 payment
  10. Amgen Inc. $22 1 payment
  11. Other $16 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $95,481 28 payments
  2. Travel and Lodging $14,636 59 payments
  3. Education $11,897 11 payments
  4. Food and Beverage $7,192 200 payments
  5. Consulting Fee $800 1 payment
Products named General payments · program years 2019–2025
  1. Sutured Construct Development Project $800 1 payment
  2. REUNION $433 7 payments
  3. DYNACORD $269 3 payments
  4. VIAFLOW $142 1 payment
  5. INBONE $142 1 payment
  6. AUGMENT INJECTABLE $142 1 payment
  7. ALLOGRAFT $137 1 payment
  8. TRUESPAN ORTHOCORD $121 1 payment
  9. BIOCLEANSE ACHILLES TENDON $105 1 payment
  10. EVOS $80 3 payments
  11. Other $676 15 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 60 billing codes

Paid by Medicare

$87,180

Of which drugs: $580

Medicare patients

329

Average age 73

Services billed

5,567

186 women, 143 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 71%
Depression 37%
Ischemic heart disease 35%
Diabetes 29%
Chronic kidney disease 24%
COPD 21%
Heart failure 19%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 57 4,880 $483
Injection, methylprednisolone acetate, 80 mg J1040 Office 13 13 $61

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
EVENITY
  • Amgen Inc. $22
$22 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

299 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record